Streetbeat News

MED

Medifast, Inc.

https://medifastinc.com

Industry

Personal Products & Services

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Open

18.16

Mkt cap

201M

Volume

77K

High

18.68

P/E Ratio

27.49

52-wk high

76.42

Low

18.06

Div yield

N/A

52-wk low

17.07

Medifast's (NYSE:MED) short interest has risen by 3.9%, with 45.02% of its float sold short. This is significantly higher than its peers' average of 5.01%. It would take traders 6.34 days to cover their short positions.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 3:30 pm

Medifast's (NYSE:MED) short interest has increased by 11.91% since the last report, with 2.99 million shares sold short, representing 41.53% of its float. This high level of short interest, compared to its peer group average of 4.98%, indicates a bearish market sentiment towards MED. However, an increase in short interest can sometimes be bullish, as covering short positions can drive the stock price up.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:30 pm

The article highlights the top 4 defensive stocks in the consumer staples sector that are currently oversold, presenting a potential buying opportunity. These include Medifast, Inc. (MED), Safety Shot, Inc. (SHOT), Molson Coors Beverage Company (TAP), and Australian Oilseeds Holdings Limited (COOT), all of which have an RSI near or below 30, indicating they may be undervalued.

Portfolio Pulse from Avi Kapoor

May 02, 2024 | 12:56 pm

H&E Equipment Services, Inc. (HEES) shares fell by 18.2% following mixed Q1 results, missing EPS estimates but beating sales expectations. Other stocks experienced significant movements, with notable gainers including Akili, Inc. (AKLI) and losers like Lichen China Limited (LICN). Various companies reported financial results, strategic partnerships, and other business updates affecting their stock prices.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 5:24 pm

DA Davidson analyst Linda Bolton Weiser maintains a Neutral rating on Medifast (NYSE:MED) and lowers the price target from $40 to $25.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 4:55 pm

The Nasdaq Composite fell over 100 points amid lower U.S. stock trading, with Coca-Cola Company reporting better-than-expected Q1 results. Health care shares slightly rose, while energy shares dropped significantly. Akili, AGBA Group Holding, and Global Mofy Metaverse saw their stocks surge on positive developments, whereas Chegg, Vince Holding, and Medifast experienced significant declines following their financial results.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 4:34 pm

U.S. stocks traded lower, with the Dow Jones falling over 200 points. McDonald's reported mixed Q1 results, missing EPS estimates but beating sales forecasts. Akili, AGBA Group, and Global Mofy Metaverse saw significant stock increases, while Lichen China, Vince Holding, and Medifast experienced notable declines. Oil prices rose slightly, while gold and silver fell. European and Asian markets showed mixed results, with various economic indicators reported.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 2:17 pm

GeneDx Holdings Corp. (NASDAQ:WGS) shares surged 37.4% in pre-market trading after reporting Q1 financial results that exceeded analyst expectations and raising its FY2024 sales guidance. Other stocks also showed significant movement in pre-market trading, with notable gainers including Cyclacel Pharmaceuticals, Greenwave Technology Solutions, and Marin Software, among others. Losers in pre-market trading included Lichen China Limited, Medifast, and iClick Interactive Asia Group.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 12:08 pm

Medifast shares are trading lower following the announcement of mixed Q1 financial results, indicating a potential concern among investors regarding the company's performance.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:14 am

Medifast reported mixed Q1 results, missing EPS estimates but beating sales expectations, leading to a 15.6% pre-market drop. Coursera, Chegg, ADC Therapeutics, Mesoblast, Coeur Mining, Prudential, Yum China, Sibanye Stillwater, and Rambus also saw pre-market declines due to various factors including disappointing financial results, leadership changes, and clinical trial updates.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 10:07 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.